- Report
- October 2021
- 40 Pages
Japan
From €1363EUR$1,500USD£1,167GBP
- Report
- October 2021
- 40 Pages
Russia
From €1363EUR$1,500USD£1,167GBP
- Report
- October 2021
- 40 Pages
South Korea
From €1363EUR$1,500USD£1,167GBP
- Report
- October 2021
- 40 Pages
Vietnam
From €1363EUR$1,500USD£1,167GBP
From €1904EUR$2,095USD£1,631GBP
€3627EUR$3,990USD£3,105GBP
- Report
- May 2025
United States
From €1904EUR$2,095USD£1,631GBP
€3627EUR$3,990USD£3,105GBP
From €1904EUR$2,095USD£1,631GBP
€3627EUR$3,990USD£3,105GBP
- Report
- May 2025
United States
From €1904EUR$2,095USD£1,631GBP
€3627EUR$3,990USD£3,105GBP
- Report
- May 2025
United Kingdom
From €1904EUR$2,095USD£1,631GBP
€3627EUR$3,990USD£3,105GBP
From €1904EUR$2,095USD£1,631GBP
€3627EUR$3,990USD£3,105GBP
- Report
- May 2025
United Kingdom
From €1904EUR$2,095USD£1,631GBP
€3627EUR$3,990USD£3,105GBP
- Report
- May 2025
North America
From €1904EUR$2,095USD£1,631GBP
€3627EUR$3,990USD£3,105GBP
- Report
- May 2025
Middle East
From €1904EUR$2,095USD£1,631GBP
€3627EUR$3,990USD£3,105GBP
- Report
- May 2025
Asia Pacific
From €1904EUR$2,095USD£1,631GBP
€3627EUR$3,990USD£3,105GBP
From €1904EUR$2,095USD£1,631GBP
€3627EUR$3,990USD£3,105GBP
From €1904EUR$2,095USD£1,631GBP
€3627EUR$3,990USD£3,105GBP
- Report
- May 2025
North America
From €1904EUR$2,095USD£1,631GBP
€3627EUR$3,990USD£3,105GBP
From €1904EUR$2,095USD£1,631GBP
€3627EUR$3,990USD£3,105GBP
- Report
- May 2025
Middle East
From €1904EUR$2,095USD£1,631GBP
€3627EUR$3,990USD£3,105GBP
- Report
- May 2025
Asia Pacific
From €1904EUR$2,095USD£1,631GBP
€3627EUR$3,990USD£3,105GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more